about
A genome-wide screen identifies YAP/WBP2 interplay conferring growth advantage on human epidermal stem cells.Epidermal barrier defects link atopic dermatitis with altered skin cancer susceptibilityTumor formation initiated by nondividing epidermal cells via an inflammatory infiltrateBLIMP1 is required for postnatal epidermal homeostasis but does not define a sebaceous gland progenitor under steady-state conditions.Rewiring of an epithelial differentiation factor, miR-203, to inhibit human squamous cell carcinoma metastasis.c-MYC-induced sebaceous gland differentiation is controlled by an androgen receptor/p53 axisImiquimod 3.75% cream (Zyclara) for the treatment of actinic keratoses.Differential Diagnosis of Palmoplantar Eczema in Psoriatico: Chronic Allergic Contact Dermatitis and/or Psoriasis?Treatment options for pyoderma gangrenosum.Insulin and insulin-like growth factor-1 can modulate the phosphoinositide-3-kinase/Akt/FoxO1 pathway in SZ95 sebocytes in vitro.Therapieoptionen beim Pyoderma gangraenosum.The interfollicular epidermis of adult mouse tail comprises two distinct cell lineages that are differentially regulated by Wnt, Edaradd, and Lrig1.Complete basal cell carcinoma remission with imiquimod in a patient with nevoid basal cell carcinoma syndrome and associated basal cell carcinoma of the scalp and invasive ductal breast cancer.Expression of epidermal stem cell markers in skin and adnexal malignancies.p53 activity contributes to defective interfollicular epidermal differentiation in hyperproliferative murine skin.White papules around the ears: a quiz. Milia en plaque.Preclinical pilot study monitoring topical drug penetration and dermal bioavailability of a peptidase inhibitor from different galenic formulations into pig dermis, using cutaneous microdialysis.Cytokine and Chemokine Recovery Is Increased by Colloid Perfusates during Dermal Microdialysis.Insulin and Insulin-like growth factor-1 can activate the phosphoinositide-3-kinase /Akt/FoxO1 pathway in T cells in vitro.High incidence of naevi-associated BRAF wild-type melanoma and dysplastic naevi under treatment with the class I BRAF inhibitor vemurafenib.Upregulation of CD26 expression in epithelial cells and stromal cells during wound-induced skin tumour formation.Cutaneous botryomycosis diagnosed long after an arm injuryGigantic Erythematous Plaques with Violaceous Oedematous Borders: A QuizComparative randomised clinical trial against glycopeptides supports the use of daptomycin as first-line treatment of complicated skin and soft-tissue infectionsSelective regional perfusion of the bilateral external carotid arteries with pegylated liposomal doxorubicin and melphalan to treat metastatic malignant melanoma of the scalpPossible Acceleration of Regression by Antibiotic Treatment in Benign Cephalic Histiocytosis with Infiltration of CD11a/CD11c+ MacrophagesPeriungual fibroma (Koenen tumors) as isolated sign of tuberous sclerosis complex with tuberous sclerosis complex 1 germline mutationDeterminanten der Patientenzufriedenheit in einer dermatologischen Universitätsklinik als Parameter zur Patientenorientierung im Rahmen des QualitätsmanagementsVernetzung als Chance zur Profilierung einer Klinik?Expression of Potential Dermal Progenitor Cell Markers in the Tumour and Stroma of Skin Adnexal Malignant and Benign Tumours
P50
Q30843628-C5A9DDF1-7627-4F64-8BA5-02A7AE82FD11Q33555117-57C1D1C6-3A53-4242-88B7-A2CE13EACCFCQ34358943-2E15A152-2C7B-4B44-B993-00834D377D8AQ34469549-CD2D5052-18CA-4BF4-A082-ABDEFA01A58EQ35952663-775FAF9E-144D-43FD-B3B6-DA6DB99149CCQ37187309-F2268B2E-1B80-47E8-8404-7FAF651D74BEQ37831354-55750DC5-9658-43D2-969A-56266392007FQ38372033-BCD7FE9F-64EA-4EC7-A425-F17CC838ACE3Q38763877-1680B134-F02C-4647-961E-D57796C1BEF9Q38844987-9BC95AC4-A7EC-46EA-8D7A-1231C234F5A8Q39111518-8078C6AA-1C6D-40CE-B8F8-06ACE7B88FB7Q42445148-EF0F5C78-EE42-4EE6-AC1A-75A69094ABAFQ42483891-66DBA412-6D79-4473-A930-572CC356A421Q42489496-BB7EC320-A512-4C99-8B7D-0A957FF1BC6FQ42880745-DE3FF1C4-6984-46FD-897D-F11057DA0A38Q43007076-E071A1A4-D5F5-4DBD-8946-4E90D7F1BBBCQ47291188-F1AC2262-5B2E-4311-85DF-D106A9FF24ACQ52804076-E448D5A3-BEF3-478A-9F96-0DB80CC967B0Q54124254-362099D2-58D5-45CA-9349-73918BDE8427Q54377025-5662AB46-EBF2-4BF6-A1DC-D250922F4867Q54573640-FFD48018-4C77-4CBC-8383-F05C2D68CCE6Q58493986-CD6B37E2-BB3D-4DBD-BE60-37300C30F64EQ58493987-B97B0E7A-E2BC-4C8C-8250-BD6923175B36Q58493989-2B713AC1-9C5F-48FC-BB63-18FF66347F76Q58493991-060F2734-97AA-4A0E-AC0A-78CA8283C96DQ58493994-AF89B85C-2DF8-4506-B706-A9F665BA7593Q58493995-FF4288D9-8980-4B0C-91A1-31EFD60243AEQ58493996-C86BF55B-B616-47DF-8F86-5B0EFD1B9FE2Q58493997-70BDE8A5-DF73-455D-90E9-AEB52AFBAB71Q64098010-74F28DC6-668B-4029-BA77-DF2F46C8C827
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sven Quist
@ast
Sven Quist
@en
Sven Quist
@es
Sven Quist
@nl
type
label
Sven Quist
@ast
Sven Quist
@en
Sven Quist
@es
Sven Quist
@nl
prefLabel
Sven Quist
@ast
Sven Quist
@en
Sven Quist
@es
Sven Quist
@nl
P214
P106
P214
P31
P496
0000-0002-9548-7813
P735
P7859
viaf-32894357